Mineralys Therapeutics (MLYS) Earnings Date & Reports

A.I. Advisor

published Earnings

MLYS is expected to report earnings to fall 14.46% to -70 cents per share on November 05

Mineralys Therapeutics MLYS Stock Earnings Reports

Q3'24

Est.

$-0.71

Q2'24

Missed

by $0.11

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.22

Q3'23

Beat

by $0.19

The last earnings report on August 13 showed earnings per share of -82 cents, missing the estimate of -72 cents. With 97.44K shares outstanding, the current market capitalization sits at 591.75M.

View a ticker or compare two or three

Compare

MLYS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MLYS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MLYS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

150 North Radnor Chester Road

Phone

+1 888 378-6240

Employees

Web

https://mineralystx.com